Patents
Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
11/2006
11/30/2006US20060270864 To produce photoresist resist material and pattern forming in a vacuum ultraviolet wavelength region
11/30/2006US20060270853 Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one
11/29/2006EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006CN1869030A Preparation method of doxytasai
11/29/2006CN1286828C Process for preparing paclitaxel
11/29/2006CN1286826C Catalytic distillation method of olefine direct epoxidation
11/29/2006CN1286823C Oxazolidine intermediate for preparing taxad alkane
11/28/2006US7141682 Liquid phase synthesis of methylene lactones using oxnitride catalyst
11/28/2006US7141670 Reacting malondiimate with diketene; chemical intermediate for agriculture products
11/28/2006CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/22/2006EP1724266A1 Process for producing 2,2,3,3-tetrafluorooxetane
11/22/2006CN1865255A Method for producing docetaxel using 10-deacetylpaclitaxel as raw material
11/22/2006CN1285583C Preparation process for hexafluropropylene oxide
11/21/2006CA2158060C Process for the preparation of .beta.-phenylisoserine derivatives
11/09/2006US20060252911 adamantyl diglycidyl ether or 1-adamantanol epichlorohydrin adduct curable to polyepoxides; encapsulant for light-emitting diode; superior optical properties, heat resistance, photostability, and shrinkage inhibition
11/08/2006EP1719769A1 Process for producing alicyclic oxetane compound
11/08/2006EP1718335A2 Drug conjugates
11/08/2006CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/08/2006CN1283243C Taxane class derivative based pharmaceutical compositions
11/07/2006US7132554 Synergistic mixture of an orally administered taxane compound and the epidermal growth factor receptor antibody, cetuximab; especially for treaing colorectal cancer, breast cancer, gastric cancer, ovarian cancer, non-small cell lung cancer and cancers of the head and neck.
11/07/2006US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006CA2210204C Mono-substituted fluorinated oxetane monomers
11/01/2006CN1856483A New polyether based monomers and highly cross-linked amphiphile resins
11/01/2006CN1854132A Production of polyenoic taxad alcohol trihydrate
10/2006
10/31/2006CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/31/2006CA2188599C Taxane class derivative based pharmaceutical compositions
10/26/2006US20060241177 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
10/26/2006US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/25/2006EP1713787A2 (meth) acryloyl group-containing oxetane compound and production method thereof
10/25/2006CN1281595C Method of producing propylene oxide by direct oxidation of propylene
10/19/2006WO2006108561A1 A process for the purification of 10-deacetylbaccatine iii from 10-de acet yl-2- debenzoyl-2-pentenoylbaccatine iii
10/19/2006US20060234999 Natural, synthetic or semi-synthetic crude harringtonines purified by chromatography and crystallization in which the solvent is water or lower C1-4 alkanol or an aqueous mixture of organic solvents; treatment of cancer through oral administration
10/19/2006US20060234882 For use as fragrance chemicals suitable for incorporation in fine fragrances, cosmetics, toiletries and related applications
10/19/2006CA2604193A1 A process for the purification of 10-deacetylbaccatine iii from 10-deacetyl-2- debenzoyl-2-pentenoylbaccatine iii
10/18/2006EP1712552A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
10/18/2006EP1712551A1 3-Methyl oxetanemethanol derivatives and their use in perfume compositions
10/18/2006CN1849311A Acetone solvate of dimethoxy docetaxel and its process of preparation
10/11/2006EP1183250B1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
10/10/2006CA2298398C Baccatin derivatives and a process for producing the same
10/10/2006CA2211808C Method for preparing 4,10-diacetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1,7.beta.-dihydroxy-9-oxo-tax-11-en-13.alpha.-yl (2r,3s)-3-benzoylamino-2-hydroxy-3-phenylpropionate trihydrate
10/10/2006CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
10/10/2006CA2157905C Process for purifying taxoids
10/05/2006WO2006104167A1 Oxetane ring-containing 1,3-propanediol derivative
10/05/2006WO2006102758A1 Preparation of taxanes from 9-dihydro-13-acetylbaccatin iii
10/05/2006WO2006014345A8 Process for the separation of paclitaxel and cephalomannin
10/04/2006EP1255747B1 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
10/04/2006EP0956284B1 Process for selective derivatization of taxanes
10/04/2006CN1842517A 芴衍生物 Fluorene derivatives
10/03/2006CA2167718C Synthesis of taxol and its derivatives
09/2006
09/28/2006WO2006102200A2 Docetaxel immunoassay
09/28/2006WO2006058681A3 Method for producing enantiomer-enriched lactones
09/28/2006US20060217537 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide
09/28/2006US20060217436 Process for the preparation of docetaxel trihydrate
09/28/2006US20060216769 Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects
09/28/2006US20060216767 Docetaxel immunoassay
09/28/2006CA2602790A1 Docetaxel immunoassay
09/27/2006EP1703904A2 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
09/26/2006US7112687 Methods for obtaining paclitaxel from taxus plants
09/21/2006WO2006097262A1 Semi-synthetic taxane derivatives with antitumor activity
09/21/2006CA2601897A1 Semi-synthetic taxane derivatives with antitumor activity
09/13/2006EP1664033A4 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
09/13/2006EP1406869B1 Taxol enhancer compounds
09/13/2006CN1274682C Process for high efficient separating high pureness taxiol half sythesizing precursor
09/12/2006US7105187 Isolating taxane and derivatives from soil from which a living plant has grown
09/08/2006WO2006093680A1 Sprayable coating composition
09/08/2006WO2006093548A1 Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
09/08/2006CA2600004A1 Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
09/08/2006CA2599394A1 Sprayable coating composition
09/06/2006EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives
09/05/2006US7102018 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6)deca -3,8-diene; for Diels-alder reaction; antitumor agents
08/2006
08/31/2006WO2006090057A1 Method for preparing paclitaxel
08/31/2006WO2006090056A1 Method for preparing docetaxel
08/31/2006CA2597174A1 Method for preparing paclitaxel
08/31/2006CA2596696A1 Method for preparing docetaxel
08/30/2006EP1695698A1 Anti-angiogene compositions and methods of use
08/30/2006EP1695697A1 Anti-angiogenic compositions and methods of use
08/30/2006EP1694660A1 Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
08/29/2006US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents
08/29/2006CA2146373C Process for preparing 10-desacetylbaccatine iii
08/24/2006US20060189810 Novel sulfonamide inhibitors of aspartyl protease
08/24/2006US20060189684 3-Phenylfuran-2-one derivatives as cox-2 inhibitor
08/23/2006CN1271061C Process for the preparation of the 14beta-hydroxy-baccatin III -1,14-carbonate
08/22/2006US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets
08/16/2006EP1363892B1 Method for the production of a stable pharmaceutical form of paclitaxel
08/15/2006US7091375 Method for the production of 2=-keto-l-gulonic acid C4C10 alkyl esters
08/15/2006US7091351 Vanadium compounds for treating cancer
08/10/2006US20060178427 chemically linking the taxane to a cell binding agent such as monoclonal antibody for tumor antigen; taxane has extra ether bridge group, and chemical group for conjugation such as mercapto
08/09/2006EP1688415A1 Cytotoxic agents comprising new C-2 modified taxanes
08/09/2006CN2804091Y Epoxy propane monotube multicyclone static mixed pipe type acrylic chlorine alcoholization reaction prodn. unit
08/09/2006CN1268619C Preparing of polyene taxol trihydrate
08/08/2006US7087273 Liquid crystalline oxetane compound, polymerizable liquid crystalline composition, method for producing liquid crystal film, optical film, and liquid crystal display
08/01/2006US7084184 Comprises polyoxetanes; for high resolution and quality imaging with no color contamination
07/2006
07/27/2006US20060167284 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
07/27/2006US20060166033 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
07/26/2006EP1683520A2 Water-soluble paclitaxel produgs
07/26/2006EP0681568B1 Process for preparation of taxane derivatives and beta-lactam intermediates therefor
07/26/2006CN1809556A Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives
07/26/2006CN1809548A Curable polycyclic compounds and process for the production thereof
07/25/2006CA2161138C Oxidation products of cephalomannine
07/18/2006US7078538 novel intermediates useful in the synthesis of 14 beta -hydroxy-1,14-carbonate-deacetylbaccatin III derivatives; 7,10-bistrichloroacetyl-10-deacetylbaccatin III; 13-dehydro-14 beta -hydroxy-7-triethylsilylbaccatin III; 13-dehydro-14 beta -hydroxy-7,10-bistrichloroacetyl-baccatin III 1,14-carbonate
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 55